HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aron S Buchman Selected Research

Arteriolosclerosis

1/2022Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias.
12/2020Neuropathologic burden and the degree of frailty in relation to global cognition and dementia.
1/2019APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults.
1/2018Brain pathology is related to total daily physical activity in older adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aron S Buchman Research Topics

Disease

19Cognitive Dysfunction
03/2022 - 07/2009
18Dementia (Dementias)
03/2022 - 02/2007
17Alzheimer Disease (Alzheimer's Disease)
01/2022 - 07/2009
7Parkinsonian Disorders (Parkinsonism)
10/2022 - 01/2016
6Atherosclerosis
10/2022 - 01/2018
6Hippocampal Sclerosis
01/2022 - 02/2016
5Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2022 - 11/2015
5Parkinson Disease (Parkinson's Disease)
01/2021 - 03/2005
4Arteriolosclerosis
01/2022 - 01/2018
4Infarction (Infarctions)
01/2022 - 10/2012
4Cerebral Infarction
12/2020 - 10/2012
3Vascular Diseases (Vascular Disease)
01/2022 - 08/2008
3Lewy Body Disease (Lewy Body Dementia)
01/2017 - 07/2015
3Stroke (Strokes)
03/2016 - 03/2005
2Inflammation (Inflammations)
01/2021 - 01/2019
2Frailty
12/2020 - 08/2008
2Type 2 Diabetes Mellitus (MODY)
05/2020 - 11/2017
2Sleep Deprivation
12/2019 - 10/2014
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2019 - 01/2019
2Brain Infarction
01/2019 - 01/2013
2Synucleinopathies
07/2015 - 02/2013
2Pain (Aches)
08/2013 - 09/2010
1Intracranial Arteriosclerosis (Cerebral Atherosclerosis)
10/2022
1Brain Diseases (Brain Disorder)
01/2022
1limbic-predominant age-related TDP-43 encephalopathy
01/2022
1Movement Disorders (Movement Disorder)
01/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Arthritis (Polyarthritis)
01/2021
1Sarcopenia
01/2021
1Neuroinflammatory Diseases
01/2021
1Neoplasms (Cancer)
01/2021
1Hypersensitivity (Allergy)
10/2016
1Hypertension (High Blood Pressure)
03/2016
1Intermittent Claudication
03/2016
1Myocardial Infarction
03/2016
1Heart Failure
03/2016
1Hypokinesia (Bradykinesia)
01/2016
1Amyloid angiopathy
11/2015
1Multiple System Atrophy
07/2015
1Constipation
07/2015
1Dyssomnias (Dyssomnia)
07/2014
1Musculoskeletal Pain
08/2013
1Chronic Pain
08/2013
1Amyloid Plaque
02/2013
1Prodromal Symptoms
07/2009
1Arthralgia (Joint Pain)
08/2008
1Chronic Disease (Chronic Diseases)
08/2008
1Sialorrhea
02/2005

Drug/Important Bio-Agent (IBA)

8Amyloid (Amyloid Fibrils)IBA
10/2021 - 03/2011
7Apolipoproteins E (ApoE)IBA
10/2019 - 01/2010
6ApolipoproteinsIBA
01/2019 - 07/2009
5DNA-Binding Proteins (DNA Binding Protein)IBA
01/2022 - 09/2015
4Proteins (Proteins, Gene)FDA Link
05/2022 - 01/2018
3Complement System Proteins (Complement)IBA
01/2021 - 01/2016
3Biological ProductsIBA
01/2021 - 01/2013
3RNA (Ribonucleic Acid)IBA
12/2019 - 01/2016
2Advanced Glycation End ProductsIBA
03/2022 - 05/2020
2Peptides (Polypeptides)IBA
01/2022 - 01/2021
2SynucleinsIBA
01/2021 - 07/2015
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 02/2016
2AntibodiesIBA
01/2019 - 06/2004
2Pharmaceutical PreparationsIBA
10/2017 - 09/2013
2Antihypertensive Agents (Antihypertensives)IBA
03/2016 - 08/2008
2Apolipoprotein E4IBA
11/2009 - 09/2009
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2022
1Dietary Advanced Glycation End ProductsIBA
03/2022
1N-(4-aminophenethyl)spiroperidol (NAPS)IBA
03/2022
1AutoantigensIBA
01/2022
1CalciumIBA
01/2022
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2022
1Serine (L-Serine)FDA Link
01/2022
1HLA-DQA1 antigen (HLA DQA1)IBA
01/2021
1lipopolysaccharide-binding proteinIBA
01/2021
1Fatty Acid-Binding ProteinsIBA
01/2021
1C-Reactive ProteinIBA
01/2019
1Matrix Metalloproteinases (MMPs)IBA
01/2019
1HaptoglobinsIBA
11/2017
1LipidsIBA
10/2017
1Adenosine Triphosphate (ATP)IBA
10/2017
1Deoxyribonucleases (DNase)FDA Link
10/2016
1Intergenic DNA (Junk DNA)IBA
10/2016
1ChromatinIBA
10/2016
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2016
1Hypnotics and Sedatives (Sedatives)IBA
01/2016
1Protein Isoforms (Isoforms)IBA
01/2016
1Codon (Codons)IBA
11/2015
1GalaninIBA
10/2014
1Pain-FreeIBA
08/2013
1Biomarkers (Surrogate Marker)IBA
08/2013
1Antiphospholipid AntibodiesIBA
01/2013
1SynaptophysinIBA
01/2013
1Glial Fibrillary Acidic ProteinIBA
01/2013
1Genetic Markers (Genetic Marker)IBA
07/2009
1Antipsychotic Agents (Antipsychotics)IBA
08/2008
1Botulinum Toxins (Botulinum Toxin)IBA
02/2005

Therapy/Procedure

8Activities of Daily Living (ADL)
01/2021 - 02/2007
2Wearable Electronic Devices
01/2021 - 01/2019
1Therapeutics
12/2020
1Glycemic Control
11/2017
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
03/2005